CLDI.WS

Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS

Overview Fund Activity
Delisted

CLDI.WS was delisted on the 17th of October, 2024.

Back to rankings

21 hedge funds and large institutions have $1.64M invested in Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
21
Holders Change
–
Holders Change %
0%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
–
Reduced
5
Closed
6
Calls
$310K
Puts
–
Net Calls
+$310K
Net Calls Change
-$533K

Top Buyers

1
SCM
Shaolin Capital Management
Florida
$143K
2
ETH
Exos TFP Holdings
New York
$23.1K
3
SOA
Sea Otter Advisors
Florida
$1.07K
4
CS
Clear Street
New York
$428
5
Bank of America
Bank of America
North Carolina
$11

Top Sellers

1
SCM
Segantii Capital Management
Hong Kong
$0
2
HCM
Highbridge Capital Management
New York
$342K
3
PC
Periscope Capital
Ontario, Canada
$44K
4
ICM
Ionic Capital Management
New York
$16.5K
5
RCM
Radcliffe Capital Management
Pennsylvania
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
AGM
26
Alpine Global Management
New York
– -$1.75K -15,400 Closed
FTUS
27
Flow Traders U.S.
New York
– -$1K -10,837 Closed
1
2